Clinical trials have shown impressive weight loss results with tirzepatide, making it an exciting option for patients who qualify
In my column on Wednesday, I was perhaps the millionth person to write about the year-old category of appetite-suppressing semaglutide weight loss drugs, with labels like Ozempic, Wegovy and Manjaro -- that are overtaking the economy and upending the traditional diet and weight loss industry
With the right size needle and proper injection site, the risk of hitting bone is unlikely
No jitters, no crashes, no gas, not bloatingjust steady natural energy and way less snacking
Results showed that A1c dropped 2.3% with Mounjaro and 1.9% with Ozempic
"We don't know what the long-term outcomes are going to be, so that is another big concern," Eichner adds